急性损伤和综合征是由"神奇药丸"引起的
Yangming Cao1,2, Thao Phan3, Patil Armenian4
1Division of Nephrology, Department of Internal Medicine, UCSF Fresno.
Clinical nephrology. Case studies
|September 22, 2025
概括
一名患者在服用痛风的"神奇药丸"后出现了性综合征和急性间歇性炎,后来发现它含有迪克洛芬雅 (一种NSAID). 这种情况通过治疗得到解决,这表明NSAIDs也可能引发IgA脏病.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
背景情况:
- 性综合征 (NS) 和急性间歇性炎 (AIN) 可能是非类固醇抗炎药物 (NSAID) 的罕见副作用.
- NSAID诱导的损伤往往呈现为AIN,但可以与其他球膜疾病同时发生.
研究的目的:
- 报告一个独特的同时发生的最小变化疾病 (MCD),AIN和IgA脏病 (IgAN) 病例,可能由二二制剂诱导.
- 强调在NS和AIN的差异诊断中考虑NSAID的重要性,即使存在其他凝聚氨基胺.
主要方法:
- 一个患有痛风的病人的病例介绍,他在服用"神奇药丸"后发展了NS和AIN.
- 脏活检分析显示MCD,AIN,急性管道损伤 (ATI) 和Igan.
- 对"神奇药丸"进行化学分析,以确定二二.
- 在普得尼松治疗和停用NSAID后的临床随访.
主要成果:
- 患者的脏状况 (NS,AIN,MCD,Igan) 显著改善,在停止使用含有NSAID的药丸和短时间服用普得尼松后得到解决.
- 狄克洛菲纳克被确定为"神奇药丸"的主要成分.
- 这种情况表明可能是NSAID (迪克洛芬雅克) 引发Igan,在6年的随访期间没有复发.
结论:
- 迪克洛菲纳克伪装成草药,引起了AIN,MCD和可能IGAN.
- 在出现NS和AIN的患者中,NSAID使用史至关重要.
- 这是NSAID诱导IGAN第一个报告的病例,该病例在6年后消失并没有复发.
相关概念视频
01:24Nephrotic Syndrome I : Introduction
504
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
504
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
271
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
271
01:20Acute Kidney Injury V: Interprofessional Care
297
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
297
01:22Acute Kidney Injury I: Introduction
581
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
581
01:29Acute Kidney Injury II: Pathophysiology
903
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
903
01:29Acute Kidney Injury III: Clinical Manifestations
827
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
827